GSK2636771
Showing 1 - 5 of 5
Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (GSK2636771, Pembrolizumab)
Active, not recruiting
- Melanoma and Other Malignant Neoplasms of Skin
- Metastatic Melanoma
- GSK2636771
- Pembrolizumab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Advanced Gastric Adenocarcinoma Trial in Seoul (GSK2636771, Paclitaxel)
Completed
- Advanced Gastric Adenocarcinoma
- GSK2636771
- Paclitaxel
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System, Yonsei Canc
Apr 21, 2021
Cancer Trial in Korea, Republic of, United Kingdom, United States (GSK2636771)
Completed
- Cancer
- GSK2636771
-
New Haven, Connecticut
- +7 more
Jul 20, 2018
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022